These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 30262796)

  • 21. Prevalence of genetic susceptibility for breast and ovarian cancer in a non-cancer related study population: secondary germline findings from a Swiss single centre cohort.
    Kraemer D; Azzarello-Burri S; Steindl K; Boonsawat P; Zweier M; Dedes KJ; Joset P; Fink D; Rauch A
    Swiss Med Wkly; 2019 Aug; 149():w20092. PubMed ID: 31422574
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Latin American Study of Hereditary Breast and Ovarian Cancer
    Oliver J; Quezada Urban R; Franco Cortés CA; Díaz Velásquez CE; Montealegre Paez AL; Pacheco-Orozco RA; Castro Rojas C; García-Robles R; López Rivera JJ; Gaitán Chaparro S; Gómez AM; Suarez Obando F; Giraldo G; Maya MI; Hurtado-Villa P; Sanchez AI; Serrano N; Orduz Galvis AI; Aruachan S; Nuñez Castillo J; Frecha C; Riggi C; Jauk F; Gómez García EM; Carranza CL; Zamora V; Torres Mejía G; Romieu I; Castañeda CA; Castillo M; Gitler R; Antoniano A; Rojas Jiménez E; Romero Cruz LE; Vallejo Lecuona F; Delgado Enciso I; Martínez Rizo AB; Flores Carranza A; Benites Godinez V; Méndez Catalá CF; Herrera LA; Chirino YI; Terrazas LI; Perdomo S; Vaca Paniagua F
    Front Oncol; 2019; 9():1429. PubMed ID: 31921681
    [No Abstract]   [Full Text] [Related]  

  • 23. A multi-gene panel study in hereditary breast and ovarian cancer in Colombia.
    Cock-Rada AM; Ossa CA; Garcia HI; Gomez LR
    Fam Cancer; 2018 Jan; 17(1):23-30. PubMed ID: 28528518
    [TBL] [Abstract][Full Text] [Related]  

  • 24.
    Rofes P; Del Valle J; Torres-Esquius S; Feliubadaló L; Stradella A; Moreno-Cabrera JM; López-Doriga A; Munté E; De Cid R; Campos O; Cuesta R; Teulé Á; Grau È; Sanz J; Capellá G; Díez O; Brunet J; Balmaña J; Lázaro C
    Genes (Basel); 2021 Jan; 12(2):. PubMed ID: 33498765
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The frequency of cancer predisposition gene mutations in hereditary breast and ovarian cancer patients in Taiwan: From BRCA1/2 to multi-gene panels.
    Sung PL; Wen KC; Chen YJ; Chao TC; Tsai YF; Tseng LM; Qiu JT; Chao KC; Wu HH; Chuang CM; Wang PH; Huang CF
    PLoS One; 2017; 12(9):e0185615. PubMed ID: 28961279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Germline EMSY sequence alterations in hereditary breast cancer and ovarian cancer families.
    Määttä KM; Nurminen R; Kankuri-Tammilehto M; Kallioniemi A; Laasanen SL; Schleutker J
    BMC Cancer; 2017 Jul; 17(1):496. PubMed ID: 28738860
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of disease-causing genes in Japanese patients with
    Kaneyasu T; Mori S; Yamauchi H; Ohsumi S; Ohno S; Aoki D; Baba S; Kawano J; Miki Y; Matsumoto N; Nagasaki M; Yoshida R; Akashi-Tanaka S; Iwase T; Kitagawa D; Masuda K; Hirasawa A; Arai M; Takei J; Ide Y; Gotoh O; Yaguchi N; Nishi M; Kaneko K; Matsuyama Y; Okawa M; Suzuki M; Nezu A; Yokoyama S; Amino S; Inuzuka M; Noda T; Nakamura S
    NPJ Breast Cancer; 2020; 6():25. PubMed ID: 32566746
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comprehensive mutation detection of BRCA1/2 genes reveals large genomic rearrangements contribute to hereditary breast and ovarian cancer in Chinese women.
    Cao WM; Zheng YB; Gao Y; Ding XW; Sun Y; Huang Y; Lou CJ; Pan ZW; Peng G; Wang XJ
    BMC Cancer; 2019 Jun; 19(1):551. PubMed ID: 31174498
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interdisciplinary risk counseling for hereditary breast and ovarian cancer: real-world data from a specialized center.
    Zang B; Helms M; Besch L; Kalmbach N; Stegen S; Blohmer JU; Speiser D
    Arch Gynecol Obstet; 2023 May; 307(5):1585-1592. PubMed ID: 36307613
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Germline variants of Brazilian women with breast cancer and detection of a novel pathogenic ATM deletion in early-onset breast cancer.
    Bandeira G; Rocha K; Lazar M; Ezquina S; Yamamoto G; Varela M; Takahashi V; Aguena M; Gollop T; Zatz M; Passos-Bueno MR; Krepischi A; Okamoto OK
    Breast Cancer; 2021 Mar; 28(2):346-354. PubMed ID: 32986223
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identifying sequence variants contributing to hereditary breast and ovarian cancer in BRCA1 and BRCA2 negative breast and ovarian cancer patients.
    Jarhelle E; Riise Stensland HMF; Hansen GÅM; Skarsfjord S; Jonsrud C; Ingebrigtsen M; Strømsvik N; Van Ghelue M
    Sci Rep; 2019 Dec; 9(1):19986. PubMed ID: 31882575
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of mutations in BRCA and MMR genes in patients affected with hereditary endometrial cancer.
    Vietri MT; D'Elia G; Caliendo G; Casamassimi A; Federico A; Passariello L; Cioffi M; Molinari AM
    Med Oncol; 2021 Jan; 38(2):13. PubMed ID: 33484353
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Guideline-Based, Multi-Gene Panel Germline Genetic Testing for at-Risk Patients with Breast Cancer.
    Abdel-Razeq H; Abujamous L; Al-Azzam K; Abu-Fares H; Bani Hani H; Alkyam M; Sharaf B; Elemian S; Tamimi F; Abuhijla F; Edaily S; Salama O; Abdulelah H; Daoud R; Abubaker M; Al-Atary A
    Breast Cancer (Dove Med Press); 2023; 15():1-10. PubMed ID: 36660366
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multigene panel testing beyond BRCA1/2 in breast/ovarian cancer Spanish families and clinical actionability of findings.
    Bonache S; Esteban I; Moles-Fernández A; Tenés A; Duran-Lozano L; Montalban G; Bach V; Carrasco E; Gadea N; López-Fernández A; Torres-Esquius S; Mancuso F; Caratú G; Vivancos A; Tuset N; Balmaña J; Gutiérrez-Enríquez S; Diez O
    J Cancer Res Clin Oncol; 2018 Dec; 144(12):2495-2513. PubMed ID: 30306255
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutation Patterns in Portuguese Families with Hereditary Breast and Ovarian Cancer Syndrome.
    Vicente R; Alpuim Costa D; Vitorino M; Mendes AD; Santos C; Fontes-Sousa M
    Cancers (Basel); 2022 Sep; 14(19):. PubMed ID: 36230639
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Next step in molecular genetics of hereditary breast/ovarian cancer: Multigene panel testing in clinical actionably genes and prioritization algorithms in the study of variants of uncertain significance.
    Castillo-Guardiola V; Rosado-Jiménez L; Sarabia-Meseguer MD; Marín-Vera M; Macías-Cerrolaza JA; García-Hernández R; Zafra-Poves M; Sánchez-Henarejos P; Moreno-Locubiche MÁ; Cuevas-Tortosa E; Arnaldos-Carrillo M; Ayala de la Peña F; Alonso-Romero JL; Noguera-Velasco JA; Ruiz-Espejo F
    Eur J Med Genet; 2022 Apr; 65(4):104468. PubMed ID: 35245693
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Population and breast cancer patients' analysis reveals the diversity of genomic variation of the BRCA genes in the Mexican population.
    Fernández-Lopez JC; Romero-Córdoba S; Rebollar-Vega R; Alfaro-Ruiz LA; Jiménez-Morales S; Beltrán-Anaya F; Arellano-Llamas R; Cedro-Tanda A; Rios-Romero M; Ramirez-Florencio M; Bautista-Piña V; Dominguez-Reyes C; Villegas-Carlos F; Tenorio-Torres A; Hidalgo-Miranda A
    Hum Genomics; 2019 Jan; 13(1):3. PubMed ID: 30630528
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Germline mutational spectrum in Armenian breast cancer patients suspected of hereditary breast and ovarian cancer.
    Moradian MM; Babikyan DT; Markarian S; Petrosyan JG; Avanesian N; Arutunyan T; Sarkisian TF
    Hum Genome Var; 2021 Feb; 8(1):9. PubMed ID: 33558524
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of BRCA1/2 pathogenic variants in patients with breast and/or ovarian cancer and their families. Analysis of 3,458 cases from Lower Silesia (Poland) according to the diagnostic algorithm of the National Cancer Control Programme.
    Doraczynska-Kowalik A; Michalowska D; Matkowski R; Czykalko E; Blomka D; Semeniuk M; Abrahamowska M; Janus-Szymanska G; Mlynarczykowska P; Szynglarewicz B; Pawlak I; Maciejczyk A; Laczmanska I
    Front Genet; 2022; 13():941375. PubMed ID: 36171877
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extended genetic analysis and tumor characteristics in over 4600 women with suspected hereditary breast and ovarian cancer.
    Öfverholm A; Törngren T; Rosén A; Arver B; Einbeigi Z; Haraldsson K; Ståhlbom AK; Kuchinskaya E; Lindblom A; Melin B; Paulsson-Karlsson Y; Stenmark-Askmalm M; Tham E; von Wachenfeldt A; Kvist A; Borg Å; Ehrencrona H
    BMC Cancer; 2023 Aug; 23(1):738. PubMed ID: 37563628
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.